期刊文献+

sAPRIL结合肽对LOVO细胞5-FU化疗敏感性的影响

A proliferation-inducing ligand-binding peptide improves chemo-sensitivity of 5-FU on colorectal LOVO cells
下载PDF
导出
摘要 目的增殖诱导配体(APRIL)与结直肠癌细胞对5-氟尿嘧啶(5-FU)的耐药性密切相关。我们前期已利用噬菌体随机肽库技术成功筛选并人工合成与s APRIL有高亲和力的结合肽。本研究旨在探讨s APRIL结合肽对结直肠癌LOVO细胞5-FU化疗敏感性的影响。方法将LOVO细胞分为PBS组、5-FU组、s APRIL结合肽+5-FU组。采用CCK-8法检测细胞增殖、流式细胞仪测定细胞周期及细胞凋亡。结果 5-FU组和s APRIL结合肽+5-FU组增殖抑制率分别为(37.62±7.07)%、(63.05±2.15)%;流式细胞仪检测各组的细胞周期显示5-FU组阻滞在S期,s APRIL结合肽+5-FU组阻滞在G0/G1期和S期,且S期阻滞效应显著强于5-FU组;三组细胞凋亡率分别为(0.21±0.09)%、(12.80±0.30)%、(17.1±0.66)%。结论 s APRIL结合肽能增强结直肠癌LOVO细胞对5-FU的化疗敏感性,有望成为结直肠癌靶向治疗的新型候选制剂。 Objective This study aimed to verify if the sAPRIL-binding peptide can enhance chemo-sensitivity of 5-FU on colorectal cancer cells. Methods LOVO cells were divided into three groups: PBS, 5-FU, and sAPRIL-binding peptide plus 5-FU. The cell growth inhibition rate was detected by CCK-8 assay, and the cell cycle and cell apoptosis were detected by flow cytometry. Results The cell growth inhibition rate was (0±0)%in PBS group, (37.62±7.07)%in 5-FUgroup, (63.05±2.15)%in sAPRIL-binding peptide plus 5-FU group, respectively. In 5-FU group, cell cycle was arrested at S phase;and in sAPRIL-binding peptide plus 5-FU group, in sAPRIL-binding peptide plus 5-FU group, cell cycle was arrested at both G0/G1 and S phases ( more markedly at S phase compared with 5-FU alone). The percentage of early apoptotic cells was (0.21±0.09)%in PBS group, (12.80±0.30)%in 5-FUgroup, and (17.1±0.66)%in sAPRIL-binding peptide plus 5-FU group, respectively. Conclusions The sAPRIL-binding peptide can enhance chemo-sensitivity of 5-FU on colorectal cancer LOVO cells. This peptide might be a new approach for molecular targeted therapy of colorectal cancer.
出处 《现代消化及介入诊疗》 2015年第4期336-338,共3页 Modern Interventional Diagnosis and Treatment in Gastroenterology
关键词 结直肠癌 增殖诱导配体 5-氟尿嘧啶 细胞增殖 细胞凋亡 Colorectal cancer A proliferation-inducing ligand 5-fluorouracil Cell proliferation Cell apoptosis
  • 相关文献

参考文献10

  • 1Moreaux J, Veyrune J L, De Vos J, et al. APRIL is overexpressed in cancer: link with tumor progression. BMC Cancer, 2009,9:83.
  • 2关婧,孙爱民,王莉慧,何美蓉.慢病毒介导RNAi抑制大肠癌细胞APRIL表达对化疗敏感性的影响[J].南方医科大学学报,2011,31(9):1600-1604. 被引量:4
  • 3Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Can- cer J Clin, 2012,62(1):10-29.
  • 4Zhang N, Yin Y, Xu S J, et al. 5-Fluorouracil: mechanisms of resis- tance and reversal strategies. Molecules, 2008,13(8): 1551-1569.
  • 5Petty RD, Samuel LM, Murray GI, et al. APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identi- fied by gene expression profiling. BMC Cancer, 2009,9:434.
  • 6Li ZJ, Cho CH. Peptides as targeting probes against tumor vascula- ture for diagnosis and drug delivery. J Transl Me& 2012,10(Suppl 1):S1.
  • 7Vessillier S, Adams G, Montero-Melendez T, et al. Molecular engi- neering of short half-life small peptides (VIP, MSH and 3MSH) fused to latency-associated peptide results in improved anti-inflam- matory therapeutics. Ann Rheum Dis, 2011,71(1):143-140.
  • 8Borghouts C, Kunz C, Groner B. Current strategies for the develop- ment of peptide-based anti-cancer therapeutics. J Pept Sci, 2005,11 (11):713-726.
  • 9Mason EF, Rathmell JC. Cell metabolism: an essential link between cell growth and apoptosis. Biochim Biophys Acta, 2011,1813(4): 645-654.
  • 10Gomes CC, Duarte AP, Diniz MG, et al. Review article: Current concepts of ameloblastoma pathogenesis. J Oral Pathol Med, 2010, 39(8):585-591.

二级参考文献10

  • 1Nijwening JH, Beijersbergen RL. Using large-scale RNAi screens to identify novel drug targets for Cancer [J]. IDrugs, 2010, 13(11): 772-7.
  • 2Jiang R, Xue S, Jin Z. Stable knockdown of MYCN by lentivirus-based RNAi inhibits human neuroblastoma cells growth in vitro and in vivo[J]. Biochem Biophys Res Commun, 2011, 410 (2): 364-70.
  • 3Taiyoh H, Kubota T, Fujiwara H, et al. NK4 gene expression enhances 5-fluorouracil-induced apoptosis of murine colon Cancer cells[J]. Anticancer Res, 2011,31 (6): 2217-24.
  • 4Cazal CM, Choosang K, Severino VG, et al. Evaluation of effect of triterpenes and limonoids on cell growth, cell cycle and apoptosis in human tumor cell line[J]. Anticancer Agents Med Chern, 2010, 10 (10): 769-76.
  • 5Hahne M, Kataoka T, Schroter M, et al. April, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth[J]. J Exp Med, 1998, 188(6): 1185-90.
  • 6Schwaller J, Went P, Matthes T, et al. Paracrine promotion of tumor development by the TNF ligand April in Hodgkin's Disease [J]. Leukemia, 2007, 21(6): 1324-7.
  • 7Sun B, Wang H, Wang X, et al. A proliferation-inducing ligand: a new biomarker for non-small cell lung cancer[J]. Exp Lung Res, 2009, 35(6): 486-500.
  • 8Mhawech-Fauceglia P, Allal A, Odunsi K, et al. Role of the tumour necrosis family ligand April in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas[J]. Eur J Cancer, 2008, 44(15): 2097-100.
  • 9Dai S, Zheng Y, Chen B, et al. Two Gln187 mutants of human soluble April inhibit proliferation of lung carcinoma A549 cells[J]. Acta Biochim Pol, 2009, 56(4): 703-10.
  • 10Sioud M. Promises and challenges in developing RNAi as a research tool and therapy[J]. Methods Mol Biol, 2011,703: 173-87.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部